Literature DB >> 29674557

Draft Genome Sequences of Interpatient and Intrapatient Epidemiologically Linked Neisseria gonorrhoeae Isolates.

Sonja Hirk1, Sarah Lepuschitz1, Adriana Cabal Rosel1,2, Steliana Huhulescu1, Marion Blaschitz1, Anna Stöger1, Silke Stadlbauer1, Petra Hasenberger1, Alexander Indra1, Daniela Schmid1, Werner Ruppitsch3, Franz Allerberger1.   

Abstract

Neisseria gonorrhoeae is the causative agent of gonorrhea and was identified by the World Health Organization as an urgent public health threat due to emerging antibiotic resistance. Here, we report 13 draft genome sequences of N. gonorrhoeae isolates derived from two epidemiologically linked cases from Austria.
Copyright © 2018 Hirk et al.

Entities:  

Year:  2018        PMID: 29674557      PMCID: PMC5908950          DOI: 10.1128/genomeA.00319-18

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Neisseria gonorrhoeae is the etiological agent of the sexually transmitted disease gonorrhea, and it poses a public health threat due to the emergence of multidrug-resistant strains (1–4). Whole-genome sequencing is considered a powerful strategy to elucidate chains of transmission (5). Here, we announce the draft genome sequences of 13 epidemiologically linked N. gonorrhoeae isolates. Two vaginal swabs, taken from a 3-year-old girl on 10 January 2018, and her rectal swab, gained on 13 January 2018, yielded N. gonorrhoeae colonies on Chocolat PolyViteX VCAT3 agar plates (bioMérieux, Marcy-l’Étoile, France). A 46-year-old male household member was sampled on 13 January 2018, and N. gonorrhoeae colonies grew from a rectal swab. Eight single colonies from the child and five from the adult were further analyzed. For each isolate, antimicrobial susceptibility was determined according to the EUCAST recommendations for gonococci (6). All 13 isolates showed resistance to penicillin G (median MIC, 6 µg/ml; range, 1.5 to 32 µg/ml), tetracycline (median MIC, 24 µg/ml; range, 24 to 64 µg/ml), and ciprofloxacin (median MIC, 0.75 µg/ml; range, 0.5 to 1.5 µg/ml), but were susceptible to ceftriaxone, cefixime, and azithromycin. Genomic DNA isolation, whole-genome sequencing, assembly, and contig filtering were performed as described previously (7). Paired-end sequencing (2 × 300 bp) generated 348,172 to 847,328 reads, with a mean coverage of 41- to 89-fold. The NCBI Prokaryotic Genome Automatic Annotation Pipeline identified 2,654 to 2,720 genes, 2,604 to 2,664 coding sequences, 273 to 305 pseudogenes, 3 to 6 rRNA genes, and 47 to 51 tRNA genes. Antimicrobial resistance genes were identified using the Comprehensive Antibiotic Resistance Database (CARD) (8). All 13 isolates had gyrA, N. meningitidis PBP2 and rpsJ, and the efflux genes farA, farB, macA, macB, mtrC, mtrD, and mtrR. In addition, blaTEM-1 was detected in three child and three household member isolates. Three isolates from the child and one from the household member carried blaTEM-90. One child isolate had blaTEM-150, and another one carried blaTEM-150 plus the efflux gene patA. All 13 isolates belonged to multilocus sequence type (MLST) 1588 (ST1588). An ad hoc core genome MLST (cgMLST) scheme comprising 1,524 targets was established using strain MS11 (ATCC BAA-1833) as a reference. Child isolates differed by zero to three alleles and household member isolates by zero to one alleles; the maximum interindividual variability of the isolates was five allelic differences. In the course of comparison with the Austrian Agency for Health and Food Safety (AGES) N. gonorrhoeae whole-genome database (currently covering 452 isolates from the years 2014 to 2018), all but one isolate differed by at least 303 alleles. An isolate gained in 2016 (strain 980016-16) from a urethral swab of an epidemiologically unrelated 32-year-old male patient, registered in the same Austrian province as the two described case patients, showed a six-allele difference. From these results, we propose a complex-type threshold of a maximum of five allelic differences for direct transmission events of N. gonorrhoeae. Our findings underline the considerable potential of whole-genome sequencing (WGS) to document chains of transmission.

Accession number(s).

This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession numbers shown in Table 1. The versions described in this paper are the first versions.
TABLE 1

Fourteen N. gonorrhoeae isolates included in BioProject PRJNA433931

StrainGenBank accession no.No. of contigsTotal length (bp)
980035-18PTPT000000001732,234,140
980036-18PTPS000000001552,227,585
980037-18PTPR000000002032,214,439
980038-18PTPQ000000001932,239,226
980039-18PTPP000000001642,214,439
980040-18PTPO000000001912,232,201
980041-18PTPN000000001562,226,960
980042-18PTPM000000001682,223,307
980043-18PTPL000000001602,217,312
980044-18PTPK000000001372,214,035
980045-18PTPJ000000001412,210,712
980046-18PTPI000000001402,217,914
980047-18PTPH000000001992,209,742
980016-16PTPG000000001782,233,553
Fourteen N. gonorrhoeae isolates included in BioProject PRJNA433931
  6 in total

Review 1.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database.

Authors:  Baofeng Jia; Amogelang R Raphenya; Brian Alcock; Nicholas Waglechner; Peiyao Guo; Kara K Tsang; Briony A Lago; Biren M Dave; Sheldon Pereira; Arjun N Sharma; Sachin Doshi; Mélanie Courtot; Raymond Lo; Laura E Williams; Jonathan G Frye; Tariq Elsayegh; Daim Sardar; Erin L Westman; Andrew C Pawlowski; Timothy A Johnson; Fiona S L Brinkman; Gerard D Wright; Andrew G McArthur
Journal:  Nucleic Acids Res       Date:  2016-10-26       Impact factor: 16.971

3.  Draft Genome Sequence of Carbapenemase-Producing Serratia marcescens Isolated from a Patient with Chronic Obstructive Pulmonary Disease.

Authors:  Sarah Lepuschitz; Sieglinde Sorschag; Burkhard Springer; Franz Allerberger; Werner Ruppitsch
Journal:  Genome Announc       Date:  2017-11-16

4.  Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study.

Authors:  Dilrini De Silva; Joanna Peters; John Paul; David W Eyre; Kevin Cole; Michelle J Cole; Fiona Cresswell; Gillian Dean; Jayshree Dave; Daniel Rh Thomas; Kirsty Foster; Alison Waldram; Daniel J Wilson; Xavier Didelot; Yonatan H Grad; Derrick W Crook; Tim Ea Peto; A Sarah Walker
Journal:  Lancet Infect Dis       Date:  2016-07-12       Impact factor: 25.071

Review 5.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting.

Authors:  Lori Newman; Jane Rowley; Stephen Vander Hoorn; Nalinka Saman Wijesooriya; Magnus Unemo; Nicola Low; Gretchen Stevens; Sami Gottlieb; James Kiarie; Marleen Temmerman
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

6.  Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015.

Authors:  Michelle J Cole; Gianfranco Spiteri; Susanne Jacobsson; Neil Woodford; Francesco Tripodo; Andrew J Amato-Gauci; Magnus Unemo
Journal:  BMC Infect Dis       Date:  2017-09-11       Impact factor: 3.090

  6 in total
  2 in total

1.  Rifampicin Resistance Associated with rpoB Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020.

Authors:  Justine Schaeffer; Kathrin Lippert; Sonja Pleininger; Anna Stöger; Petra Hasenberger; Silke Stadlbauer; Florian Heger; Angelika Eigentler; Alexandra Geusau; Alexander Indra; Franz Allerberger; Werner Ruppitsch
Journal:  Microbiol Spectr       Date:  2022-06-09

2.  Association of Phylogenomic Relatedness among Neisseria gonorrhoeae Strains with Antimicrobial Resistance, Austria, 2016-2020.

Authors:  Justine Schaeffer; Kathrin Lippert; Sonja Pleininger; Anna Stöger; Petra Hasenberger; Silke Stadlbauer; Florian Heger; Angelika Eigentler; Alexandra Geusau; Alexander Indra; Franz Allerberger; Werner Ruppitsch
Journal:  Emerg Infect Dis       Date:  2022-08       Impact factor: 16.126

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.